Title | Description |
|---|---|
| Trial ID | KF9906/03 |
| Compound | Faxeladol |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 2 |
| Brief title | A randomized, multi-center, double blind, parallel-group study assessing the analgesic efficacy and safety of different dosages of GRT0151Y BID compared to active comparator BID and placebo BID in subjects with chronic knee-joint osteoarthritis |
| Indication | Polyneuropathy |
| UTN | |
| CTG ID | NCT03783910 |
| CTIS ID (former EudraCT) | |
| Trial status | Completed |
| FPI | September 19, 2005 |
| LPO | October 20, 2006 |
| Countries | Austria, Belgium, Germany, Spain, United States |
| Gender | All |
| Age | 18 Years to 75 Years |
| Results | No |
| Pubmed | |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.